Cosmos Study December 5, 2024 Dual-Team Study Team A:Kersten Bartelt, RNGregory Edwards, PhD Team B:Christopher Alban, MDEric Barkley Key Findings Patients with diabetes who are prescribed semaglutide, exenatide, liraglutide, or dulaglutide experience a 2344% reduced likelihood of dementia compared to those prescribed other diabetes management medications
10.1242/jcs.199562 J
Serum Biochemistry Analysis After 18 days of treatment, blood samples were collected after 12 h of fasting and centrifuged at 3000 rpm for 5 min to obtain the supernatant
Supports smoother, healthier skin texture
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy [19]
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in peptide metabolism pathwaysincluding GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313